Chlorzoxazone

Modify Date: 2026-07-01 22:36:27

Chlorzoxazone Structure
Chlorzoxazone structure
Common Name Chlorzoxazone
CAS Number 95-25-0 Molecular Weight 169.565
Density 1.5±0.1 g/cm3 Boiling Point 336.9±34.0 °C at 760 mmHg
Molecular Formula C7H4ClNO2 Melting Point 191-192 °C(lit.)
MSDS Chinese USA Flash Point 157.5±25.7 °C
Symbol GHS07
GHS07
Signal Word Warning

 Use of Chlorzoxazone


Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes.Chlorzoxazone is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans.

 Names

This table lists Chinese names, IUPAC names and various aliases of this chemical substance.

Name Chlorzoxazone
Synonym More Synonyms

 Chlorzoxazone Biological Activity

This table contains bioactivity, target information and biological‑assay experimental data of this compound.

Description Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes.Chlorzoxazone is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans.
Related Catalog
References

[1]. Yamamura Y, et al. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies. Xenobiotica. 2015 Apr;45(4):353-360.

 Chemical & Physical Properties

This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.

Density 1.5±0.1 g/cm3
Boiling Point 336.9±34.0 °C at 760 mmHg
Melting Point 191-192 °C(lit.)
Molecular Formula C7H4ClNO2
Molecular Weight 169.565
Flash Point 157.5±25.7 °C
Exact Mass 168.993057
PSA 46.26000
LogP 2.29
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.674
InChIKey TZFWDZFKRBELIQ-UHFFFAOYSA-N
SMILES O=c1[nH]c2cc(Cl)ccc2o1
Water Solubility 0.1 g/100 mL

 MSDS

This table provides MSDS information including hazard classification, first‑aid, fire‑fighting, spill handling, operation and storage instructions.

 Toxicological Information

This table summarizes toxicological test data, acute & chronic toxicity and ecological hazard parameters for this chemical.

CHEMICAL IDENTIFICATION

RTECS NUMBER :
DM5250000
CHEMICAL NAME :
2-Benzoxazolinone, 5-chloro-
CAS REGISTRY NUMBER :
95-25-0
LAST UPDATED :
199701
DATA ITEMS CITED :
10
MOLECULAR FORMULA :
C7-H4-Cl-N-O2
MOLECULAR WEIGHT :
169.57
WISWESSER LINE NOTATION :
T56 BMVOJ HG

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
763 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - muscle weakness Behavioral - ataxia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 129,75,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - muscle weakness Behavioral - ataxia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 129,75,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
440 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 17,242,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD277-689
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
170 mg/kg
TOXIC EFFECTS :
Behavioral - anticonvulsant
REFERENCE :
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH Volume(issue)/page/year: 19,247,1962
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
662 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - muscle weakness Behavioral - ataxia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 129,75,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - hamster
DOSE/DURATION :
166 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - muscle weakness Behavioral - ataxia
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 129,75,1960
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex)
REFERENCE :
CHTPBA Chimica Therapeutica. (Paris, France) V.1-8, 1965-73. For publisher information, see EJMCA5. Volume(issue)/page/year: 6,65,1971 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X5399 No. of Facilities: 24 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 666 (estimated) No. of Female Employees: 403 (estimated)

 Safety Information

This table covers safety warnings, protective measures, incompatible substances and disposal guidelines for this compound.

Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H302-H315-H319-H335
Precautionary Statements P301 + P312 + P330-P305 + P351 + P338
Personal Protective Equipment dust mask type N95 (US);Eyeshields;Gloves
Hazard Codes Xi:Irritant
Risk Phrases R36/37/38
Safety Phrases S26-S36-S24/25-S37/39
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS DM5250000
HS Code 2934999090

 Customs

This table shows customs‑related data including HS‑code, tariff and regulatory conditions for import and export.

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles74

More Articles

This table lists relevant public references with title, journal and publication metadata for this compound.

Effect of commercially available green and black tea beverages on drug-metabolizing enzymes and oxidative stress in Wistar rats.

Food Chem. Toxicol. 70 , 120-7, (2014)

The effect of commercially available green tea (GT) and black tea (BT) drinks on drug metabolizing enzymes (DME) and oxidative stress in rats was investigated. Male Wistar rats were fed a laboratory c...

Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.

Drug Metab. Dispos. 43 , 1408-16, (2015)

The common marmoset (Callithrix jacchus), a small New World monkey, has the potential for use in human drug development due to its evolutionary closeness to humans. Four novel cDNAs, encoding cytochro...

Effects of age increase on hepatic expression and activity of cytochrome P450 in male C57BL/6 mice.

Arch. Pharm. Res. 38 , 857-64, (2015)

Effects of aging on hepatic expression and activity of cytochrome P450 (CYP) isoforms were investigated in male mice aged 2, 6, 18, and 30 months. Microsomal protein, total CYP, cytochrome b5 and NADP...

 ChlorzoxazoneBioassay

View more

This table contains target information, in‑vitro & in‑vivo assay data for this compound.

Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
Name: Antiinflammatory activity in Kunming mouse assessed as inhibition of xylene-induced e...
Source: ChEMBL
Target: Mus musculus
External Id: CHEMBL2353532
Name: Increase the activity of the Burkholderia fixLJ 2-component system
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
Target: Burkholderia multivorans
External Id: HMS1625
Name: Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
Source: NCGC
External Id: APP-Toga-CHIKV-nsp2-p
Total 772, Current Page 1 of 78
1
2
3
4
5

 Synonyms

This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.

Myoflexin
chlorzoxazone
chloroxazone
5-chloro-2(3h)-benzoxazolone
T56 BN DOJ CQ GG
Chlorzoxazone (350 mg)
Paraflex
CHLORZOXAZONE-D3
EINECS 202-403-9
CHLORZOXANE
Biomioran
5-chloro-3H-benzooxazol-2-one
Solaxin
Myoflexine
MFCD00005717
5-Chloro-2-benzoxazolone
Chlorzoxazon
Chlorzoxazone-13C,15N,D2
5-chloro-3H-1,3-benzoxazol-2-one
5-Chlor-2-hydroxy-benzoxazol
5-Chloro-1,3-benzoxazol-2(3H)-one
5-CHLOROBENZOXAZOL-2-ONE
T56 BMVOJ GG
5-Chloro-2-hydroxybenzoxazole
Pathorysin
CHLOROXAZON

 Chlorzoxazone | FAQ

This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.

Q: What is the CAS number of Chlorzoxazone?
A: CAS number of Chlorzoxazone is 95-25-0.
Q: What is the polar surface area (PSA) of Chlorzoxazone?
A: Polar surface area (PSA) of Chlorzoxazone is 46.26000.
Q: What is the safety information for Chlorzoxazone?
A: Safety information for Chlorzoxazone: S26-S36-S24/25-S37/39.
Q: What is the SMILES notation of Chlorzoxazone?
A: SMILES notation of Chlorzoxazone is O=c1[nH]c2cc(Cl)ccc2o1.
Q: What is the molecular weight of Chlorzoxazone?
A: Molecular weight of Chlorzoxazone is 169.565.
Q: What is the InChIKey of Chlorzoxazone?
A: InChIKey of Chlorzoxazone is TZFWDZFKRBELIQ-UHFFFAOYSA-N.
Q: What is the English name of Chlorzoxazone?
A: The English name of Chlorzoxazone is Chlorzoxazone.
Q: What is the LogP of Chlorzoxazone?
A: LogP of Chlorzoxazone is 2.29.
Q: What is the boiling point of Chlorzoxazone?
A: Boiling point of Chlorzoxazone is 336.9±34.0 °C at 760 mmHg.
Q: What are the uses of Chlorzoxazone?
A: Main uses of Chlorzoxazone: Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes.Chlorzoxazone is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans.

 Chlorzoxazonefactory

This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.

Shanghai Nianxing Industrial Co., Ltd
Dayang Chem (Hangzhou) Co., Ltd.
Henan Tianfu Chemical Co., Ltd.
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.